SAN DIEGO, May 18 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO - News) announced today that Carl W. Hull has formally succeeded the Company's long-time leader, Henry L. Nordhoff, as chief executive officer (CEO). Mr. Hull, formerly Gen-Probe's president and chief operating officer, also has joined the Company's board of directors.
As first announced on March 23, Mr. Nordhoff retired as CEO yesterday. Mr. Nordhoff, who had served as Gen-Probe's CEO since 1994, is now non-executive chairman following his re-election to the board at the Company's annual meeting of stockholders last week.
"Hank Nordhoff has built a successful and dynamic company in his 15 years at the helm of Gen-Probe, and helped safeguard the health of literally millions of people worldwide through our blood screening and infectious disease testing products," Mr. Hull said. "I am honored by the opportunity to succeed him, and look forward to his continued guidance as chairman of our board."
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,200 people. For more information, go to www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release relating to expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements regarding the plans and objectives of management are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied. Some of these risks include, but are not limited to, the risk that we cannot retain key executives. For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we file with the SEC, including our most recent annual report on Form 10-K and all subsequent periodic reports. We assume no obligation and expressly disclaim any duty to update forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.
Contact: Michael Watts Vice president, investor relations and corporate communications 858-410-8673
